169 related articles for article (PubMed ID: 34127199)
1. Genome-wide detection and analysis of CRISPR-Cas off-targets.
Rodríguez TC; Dadafarin S; Pratt HE; Liu P; Amrani N; Zhu LJ
Prog Mol Biol Transl Sci; 2021; 181():31-43. PubMed ID: 34127199
[TBL] [Abstract][Full Text] [Related]
2. GUIDEseq: a bioconductor package to analyze GUIDE-Seq datasets for CRISPR-Cas nucleases.
Zhu LJ; Lawrence M; Gupta A; Pagès H; Kucukural A; Garber M; Wolfe SA
BMC Genomics; 2017 May; 18(1):379. PubMed ID: 28506212
[TBL] [Abstract][Full Text] [Related]
3. Massively parallel CRISPR off-target detection enables rapid off-target prediction model building.
Tian R; Cao C; He D; Dong D; Sun L; Liu J; Chen Y; Wang Y; Huang Z; Li L; Jin Z; Huang Z; Xie H; Zhao T; Zhong C; Hong Y; Hu Z
Med; 2023 Jul; 4(7):478-492.e6. PubMed ID: 37279759
[TBL] [Abstract][Full Text] [Related]
4. OffScan: a universal and fast CRISPR off-target sites detection tool.
Cui Y; Liao X; Peng S; Tang T; Huang C; Yang C
BMC Genomics; 2020 Mar; 21(Suppl 1):872. PubMed ID: 32138651
[TBL] [Abstract][Full Text] [Related]
5. CRISPR-offinder: a CRISPR guide RNA design and off-target searching tool for user-defined protospacer adjacent motif.
Zhao C; Zheng X; Qu W; Li G; Li X; Miao YL; Han X; Liu X; Li Z; Ma Y; Shao Q; Li H; Sun F; Xie S; Zhao S
Int J Biol Sci; 2017; 13(12):1470-1478. PubMed ID: 29230095
[TBL] [Abstract][Full Text] [Related]
6. GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases.
Tsai SQ; Zheng Z; Nguyen NT; Liebers M; Topkar VV; Thapar V; Wyvekens N; Khayter C; Iafrate AJ; Le LP; Aryee MJ; Joung JK
Nat Biotechnol; 2015 Feb; 33(2):187-197. PubMed ID: 25513782
[TBL] [Abstract][Full Text] [Related]
7. An introduction and use of the CRISPR-Cas systems.
Singh V
Prog Mol Biol Transl Sci; 2021; 179():1-10. PubMed ID: 33785173
[TBL] [Abstract][Full Text] [Related]
8. Doxycycline-Dependent Self-Inactivation of CRISPR-Cas9 to Temporally Regulate On- and Off-Target Editing.
Kelkar A; Zhu Y; Groth T; Stolfa G; Stablewski AB; Singhi N; Nemeth M; Neelamegham S
Mol Ther; 2020 Jan; 28(1):29-41. PubMed ID: 31601489
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Homology-Independent CRISPR-Cas9 Off-Target Assessment Methods.
Chaudhari HG; Penterman J; Whitton HJ; Spencer SJ; Flanagan N; Lei Zhang MC; Huang E; Khedkar AS; Toomey JM; Shearer CA; Needham AW; Ho TW; Kulman JD; Cradick TJ; Kernytsky A
CRISPR J; 2020 Dec; 3(6):440-453. PubMed ID: 33346710
[TBL] [Abstract][Full Text] [Related]
10. Defining genome-wide CRISPR-Cas genome-editing nuclease activity with GUIDE-seq.
Malinin NL; Lee G; Lazzarotto CR; Li Y; Zheng Z; Nguyen NT; Liebers M; Topkar VV; Iafrate AJ; Le LP; Aryee MJ; Joung JK; Tsai SQ
Nat Protoc; 2021 Dec; 16(12):5592-5615. PubMed ID: 34773119
[TBL] [Abstract][Full Text] [Related]
11. Modification of Cas9, gRNA and PAM: Key to further regulate genome editing and its applications.
Gupta R; Gupta D; Ahmed KT; Dey D; Singh R; Swarnakar S; Ravichandiran V; Roy S; Ghosh D
Prog Mol Biol Transl Sci; 2021; 178():85-98. PubMed ID: 33685601
[TBL] [Abstract][Full Text] [Related]
12. CASowary: CRISPR-Cas13 guide RNA predictor for transcript depletion.
Krohannon A; Srivastava M; Rauch S; Srivastava R; Dickinson BC; Janga SC
BMC Genomics; 2022 Mar; 23(1):172. PubMed ID: 35236300
[TBL] [Abstract][Full Text] [Related]
13. Identifying genome-wide off-target sites of CRISPR RNA-guided nucleases and deaminases with Digenome-seq.
Kim D; Kang BC; Kim JS
Nat Protoc; 2021 Feb; 16(2):1170-1192. PubMed ID: 33462439
[TBL] [Abstract][Full Text] [Related]
14. CRISPR Guide RNA Validation In Vitro.
Grainger S; Lonquich B; Oon CH; Nguyen N; Willert K; Traver D
Zebrafish; 2017 Aug; 14(4):383-386. PubMed ID: 27829120
[TBL] [Abstract][Full Text] [Related]
15. CALITAS: A CRISPR-Cas-aware ALigner for
Fennell T; Zhang D; Isik M; Wang T; Gotta G; Wilson CJ; Marco E
CRISPR J; 2021 Apr; 4(2):264-274. PubMed ID: 33876962
[TBL] [Abstract][Full Text] [Related]
16. TEG-seq: an ion torrent-adapted NGS workflow for in cellulo mapping of CRISPR specificity.
Tang PZ; Ding B; Peng L; Mozhayskiy V; Potter J; Chesnut JD
Biotechniques; 2018 Nov; 65(5):259-267. PubMed ID: 30114933
[TBL] [Abstract][Full Text] [Related]
17. CRISPR GUARD protects off-target sites from Cas9 nuclease activity using short guide RNAs.
Coelho MA; De Braekeleer E; Firth M; Bista M; Lukasiak S; Cuomo ME; Taylor BJM
Nat Commun; 2020 Aug; 11(1):4132. PubMed ID: 32807781
[TBL] [Abstract][Full Text] [Related]
18. Advances in detecting and reducing off-target effects generated by CRISPR-mediated genome editing.
Li J; Hong S; Chen W; Zuo E; Yang H
J Genet Genomics; 2019 Nov; 46(11):513-521. PubMed ID: 31911131
[TBL] [Abstract][Full Text] [Related]
19. In Silico Meets In Vivo: Towards Computational CRISPR-Based sgRNA Design.
Chuai GH; Wang QL; Liu Q
Trends Biotechnol; 2017 Jan; 35(1):12-21. PubMed ID: 27418421
[TBL] [Abstract][Full Text] [Related]
20. Chimeric DNA-RNA Guide RNA Designs.
Lu S; Zhang Y; Yin H
Methods Mol Biol; 2021; 2162():79-85. PubMed ID: 32926379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
